Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Tobacco Use Disorder 1Mouth Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Fanconi Anemia 1Erythroplasia 1

Interventions

fludarabine phosphate 9Cyclophosphamide 8Cyclosporine 7Busulfan 6Antilymphocyte Serum 6fludarabine 5Melphalan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Rivaroxaban 3Radiotherapy 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2ferric carboxymaltose 2apixaban 2Whole-Body Irradiation 2Therapeutics 2Methotrexate 2Heparin, Low-Molecular-Weight 2Hematologic Tests 2Genetic Counseling 2Fondaparinux 2Enoxaparin 2Educational Status 2Drug Therapy 2Dalteparin 2Cytarabine 2sulforaphane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Molecular Diagnostic Techniques × Classical hematology × Clear all
NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
338 enrolled
Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡